NCT07506486

Brief Summary

This pilot randomized controlled trial aims to evaluate the effectiveness of cognitive rehabilitation using an immersive Virtual Reality (VR) system compared to conventional paper-and-pencil cognitive training in subacute stroke patients. A total of 22 participants will be randomly assigned to either the VR intervention group (n=11) or the conventional control group (n=11). The study will measure changes in cognitive function and functional independence

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Apr 2026Sep 2026

First Submitted

Initial submission to the registry

March 26, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 1, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

April 15, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Expected
Last Updated

April 1, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

March 26, 2026

Last Update Submit

March 26, 2026

Conditions

Keywords

cognitive impairment

Outcome Measures

Primary Outcomes (2)

  • Change in Cognitive Function Assessed by Montreal Cognitive Assessment - Indonesian Version (MoCA-INA)

    The MoCA-INA assesses several cognitive domains including visuospatial/executive, naming, memory, attention, language, abstraction, delayed recall, and orientation. The total score ranges from 0 to 30, with higher scores indicating better cognitive function. A score of 26 or above is generally considered normal.

    Baseline and Post-Intervention (Week 8)

  • Change in Functional Activity Assessed by Functional Independence Measure (FIM)

    The FIM is an 18-item measurement tool that explores an individual's physical, psychological, and social function. The tool assesses the level of independence a patient has in daily tasks. Total scores range from 18 to 126, with higher scores indicating a higher level of functional independence

    Baseline and Post-Intervention (Week 8)

Study Arms (2)

Experimental: Immersive VR Cognitive Rehabilitation

EXPERIMENTAL

articipants in this group (n=11) will receive cognitive rehabilitation sessions using an immersive Virtual Reality (VR) headset and software, in addition to standard stroke care

Device: Immersive Virtual Reality System

Active Comparator: Conventional Cognitive Rehabilitation

ACTIVE COMPARATOR

Participants in this group (n=11) will receive standard cognitive rehabilitation using conventional paper-and-pencil tasks, in addition to standard stroke care.

Behavioral: Conventional Paper-and-Pencil Cognitive Training

Interventions

Intervention Description: Treatment Method: Participants will wear a fully immersive VR headset to engage in interactive, gamified virtual environments specifically designed to stimulate cognitive domains (memory, attention, visuospatial, and executive functions). Duration \& Frequency: Each VR session will last for \[30 to 45 minutes\]. The treatment will be administered at a frequency of \[3 sessions per week\] for a total duration of \[8 consecutive weeks\]. Standard Care: This intervention is provided in addition to the hospital's standard conventional stroke rehabilitation program (e.g., standard physical therapy).

Experimental: Immersive VR Cognitive Rehabilitation

Intervention Description: Treatment Method: Participants will perform standardized paper-and-pencil tasks, puzzles, and therapeutic worksheets guided by a therapist, targeting identical cognitive domains (memory, attention, visuospatial, and executive functions) as the experimental group. Duration \& Frequency: Each conventional session will last for \[30 to 45 minutes\] to match the experimental arm. The treatment will be administered at a frequency of \[3 sessions per week\] for a total duration of \[8 consecutive weeks\]. Standard Care: This intervention is provided in addition to the hospital's standard conventional stroke rehabilitation program.

Active Comparator: Conventional Cognitive Rehabilitation

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female aged 40-59 years old Stroke patient 2-4 months onset of stroke Burnstorm stage V or above First-time stroke that has been diagnosed by a neurologist with CT scan and/or MRI Stroke risk factors and comorbidities are controlled with medication Mild and moderate level of cognitive impairment based on MOCA and can use devices Participants can grip and operate VR console with their hand Participants can follow instructions and exercises Participants were cooperative and willing to participate in the study by signing a consent form after receiving an explanation.

You may not qualify if:

  • Participants with severe cognitive impairment or aphasia struggle to understand instructions Neglected patient Participants with low vision unable to perceive content on screens Participant with eyestrain characterized by blurring vision, dry eyes, foreign body sensation, itching watering, neck stiffness and backache Severe musculoskeletal disorders causing problem in standing and following instruction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RSUD Majalengka

Majalengka, West Java, 45411, Indonesia

Location

MeSH Terms

Conditions

StrokeCognitive Dysfunction

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Central Study Contacts

Farida Arisanti, MD, PMR, Neurorehab Consultant

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2026

First Posted

April 1, 2026

Study Start

April 15, 2026

Primary Completion

June 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

April 1, 2026

Record last verified: 2026-03

Locations